Evidence map›Paper›PMID 28725790›Full record

ArticleAcademic pathology

Biobanking-Budgets and the Role of Pathology Biobanks in Precision Medicine.

Chris Andry, Elizabeth Duffy, Christopher A Moskaluk, Shannon McCall, Michael H A Roehrl, Daniel Remick

Abstract read
In one paragraph

Article in Academic pathology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Sustainable biobanks: a case study for a green global bioethics.Global bioethics = Problemi di bioetica · 2022
    Article
  5. Article
  6. Article
  7. Basic principles of biobanking: from biological samples to precision medicine for patients.Virchows Archiv : an international journal of pathology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Pathology and Biobanking.Turk patoloji dergisi · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chris AndryBoston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Elizabeth DuffyBoston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Christopher A MoskalukDepartment of Pathology, University of Virginia, Charlottesville, VA, USA.
Shannon McCallDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0003-3957-061X
Michael H A RoehrlMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Daniel RemickBoston Medical Center and Boston University School of Medicine, Boston, MA, USA.ORCID 0000-0002-2615-3713

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Mechanisms of phagocytic cell defects induced by inhibitory IgGR21AI112887 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI REMICK, DANIEL G. · 2014 to 2015
$450k
Alcohol Triggered Asthma: Mechanisms of Neuronal ControlR21AA022122 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI REMICK, DANIEL G. · 2014 to 2015
$424k
NCI NIH HHS P30 CA008748NIAAA NIH HHS R21 AA022122NIAID NIH HHS R21 AI112887
6 · The paper itself

Abstract

Biobanks have become an important component of the routine practice of pathology. At the 2016 meeting of the Association of Pathology Chairs, a series of presentations covered several important aspects of biobanking. An often overlooked aspect of biobanking is the fiscal considerations. A biobank budget must address the costs of consenting, procuring, processing, and preserving high-quality biospecimens. Multiple revenue streams will frequently be necessary to create a sustainable biobank; partnering with other key stakeholders has been shown to be successful at academic institutions which may serve as a model. Biobanking needs to be a deeply science-driven and innovating process so that specimens help transform patient-centered clinical and basic research (ie, fulfill the promise of precision medicine). Pathology's role must be at the center of the biobanking process. This ensures that optimal research samples are collected while guaranteeing that clinical diagnostics are never impaired. Biobanks will continue to grow as important components in the mission of pathology, especially in the era of precision medicine.

Indexed as

biorepositoryinformed consentprecision medicineThe Cancer Genome Atlasthe Cancer Human Biobank

Identifiers

PMID28725790
PMCPMC5497908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.